论文部分内容阅读
近年来,新一代核苷类抗病毒药物拉米夫定(贺普丁)等的临床应用,是慢性乙型肝炎治疗学上的重要进步。我们应用该药治疗慢性乙肝和乙肝肝硬变,取得了较好疗效。现将拉米夫定治疗慢性乙肝和乙肝肝硬变患者血清乙肝病毒(HBV)标志物的变化情况报告如下。资料与方法:52例慢性HBV感染
In recent years, the clinical application of a new generation of nucleoside antiviral drug lamivudine (Lamudin) is an important progress in the treatment of chronic hepatitis B. We use the drug treatment of chronic hepatitis B and hepatitis B cirrhosis, and achieved good results. Now lamivudine treatment of chronic hepatitis B and hepatitis B cirrhosis patients with changes in serum hepatitis B virus (HBV) markers are reported below. Materials and Methods: 52 cases of chronic HBV infection